Skip to content

NEW E-Guide! The ROI of Smarter Care
Using Population Health Analytics to Demonstrate Value and Impact
Read Now

Documents

papers

Common comorbidity scales were similar in their ability to predict health care costs and mortality

Published: October 1, 2004
Category: Bibliography > Papers
Authors: Callahan CM, Hope C, Katon W, Kroenke K, Perkins AJ, Unutzer J, Williams JW Jr
Countries: United States
Language: null
Types: Care Management
Settings: Academic

J Clin Epidemiol 57:1040-1048.

Indiana University Center for Aging Research, Indianapolis, IN, USA

OBJECTIVE: To compare the ability of commonly used measures of medical comorbidity (ambulatory care groups [ACGs], Charlson comorbidity index, chronic disease score, number of prescribed medications, and number of chronic diseases) to predict mortality and health care costs over 1 year.

STUDY DESIGN AND SETTING: A prospective cohort study of community-dwelling older adults (n=3,496) attending a large primary care practice.

RESULTS: For predicting health care charges, the number of medications had the highest predictive validity (R(2)=13.6%) after adjusting for demographics. ACGs (R(2)=16.4%) and the number of medications (15.0%) had the highest predictive validity for predicting ambulatory visits. ACGs and the Charlson comorbidity index (area under the receiver operator characteristic [ROC] curve=0.695-0.767) performed better than medication-based measures (area under the ROC curve=0.662-0.679) for predicting mortality. There is relatively little difference, however, in the predictive validity across these scales.

CONCLUSION: In an outpatient setting, a simple count of medications may be the most efficient comorbidity measure for predicting utilization and health-care charges over the ensuing year. In contrast, diagnosis-based measures have greater predictive validity for 1-year mortality. Current comorbidity measures, however, have only poor to moderate predictive validity for costs or mortality over 1 year.

PMID: 15528055

Mortality Prediction,Cost Burden Evaluation,Co-morbidity,Resource Utilization,United States,African Americans,Aged,Ambulatory Care/economics,Cause of Death,Chronic Disease,Gender,Polypharmacy,Predictive Value of Tests,Prognosis,Prospective Studies

Please log in/register to access.